Actionable news
All posts from Actionable news
Actionable news in BDX: BECTON DICKINSON AND CO.,

BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX™ Vaginal Panel

FRANKLIN LAKES, N.J., May 13, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) BDX, +1.04% a leading global medical technology company, today announced that it obtained CE mark for the BD MAX™ Vaginal Panel. The new in vitro diagnostic (IVD) assay will provide laboratories and clinicians the ability to use a single test to detect microorganisms responsible for Bacterial Vaginosis (BV), Candidiasis (CA) and Trichomoniasis (TV), which are the most common infectious causes of vaginitis [1] .

Vaginal infections are one of the most common infections affecting women's health, with up to 75 percent of women experiencing at least one case of Vaginitis (CA, TV) or Vaginosis (BV) in their lifetime [1,2] . Both co-infections (up to 20 percent) and recurring infections are common [3,4] , resulting in a large disease burden. Pervasive inaccurate and inconsistent diagnosis of these conditions, due in part to variations in clinical practice, leaves up to 30 percent of the women seeking treatment undiagnosed. This can lead to continued symptoms, repeat visits, inappropriate or missed treatment and unnecessary associated healthcare system costs [1] . In addition to irritating symptoms that disrupt quality of life, these infections have serious risks, including pre-term or low birth-weight babies, late term miscarriage and increased risk of STI transmission or...